Stay updated on Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial page.

Latest updates to the Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial page
- Check4 days agoChange DetectedThe NIH transition notice about updated terminology and related FAQs was removed from the top of the page.SummaryDifference1%

- Check11 days agoChange DetectedThe footer now shows site revision v3.8.0 instead of v3.7.2. The page still displays a 403 error rather than the study record.SummaryDifference0.2%

- Check18 days agoChange DetectedA sitewide NIH notice announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision label updated from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record with an access-restricted message and standard site footer/navigation; the content related to the NCT02813265 study appears removed.SummaryDifference18%

Stay in the know with updates to Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of KPI-121 in Dry Eye Disease Clinical Trial page.